Bin He

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Radical Prostatectomy

Epidermal Growth Factor Receptor

Top Venues

Science translational medicine

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Tianyi Zhou, Steven Nguyen, Jacky Wu, Bin He, Qin Feng
LncRNA LOC730101 Promotes Darolutamide Resistance in Prostate Cancer by Suppressing miR-1-3p. Cancers 16 (14) (2024)
Tianyi Zhou, Steven Nguyen, Jacky Wu, Bin He, Qin Feng
LncRNA LOC730101 Promotes Darolutamide Resistance in Prostate Cancer by Suppressing miR-1-3p. Cancers 16 (14) (2024)
Tianyi Zhou, Steven Nguyen, Jacky Wu, Bin He, Qin Feng
LncRNA LOC730101 Promotes Darolutamide Resistance in Prostate Cancer by Suppressing miR-1-3p. Cancers 16 (14) (2024)
Yujing Li, Yifan Sun, Michael Kulke, Torsten Hechler, Kevin Van der Jeught, Tianhan Dong, Bin He, Kathy D Miller, Milan Radovich, Bryan P Schneider, Andreas Pahl, Xinna Zhang, Xiongbin Lu
Targeted immunotherapy for HER2-low breast cancer with 17p loss. Science translational medicine 13 (580) (2021)
Gustavo Della-Flora Nunes, Emma R Wilson, Leandro N Marziali, Edward Hurley, Nicholas Silvestri, Bin He, Bert W O' Malley, Bogdan Beirowski, Yannick Poitelon, Lawrence Wrabetz, Maria Laura Feltri
Prohibitin 1 is essential to preserve mitochondria and myelin integrity in Schwann cells. Nature communications 12 (1) (2021)